Walleye Capital LLC Journey Medical Corp Transaction History
Walleye Capital LLC
- $54.6 Billion
- Q1 2024
A detailed history of Walleye Capital LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Walleye Capital LLC holds 134,396 shares of DERM stock, worth $757,993. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134,396
Previous 22,200
505.39%
Holding current value
$757,993
Previous $127,000
288.98%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DERM
# of Institutions
36Shares Held
2.68MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$4.88 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA310KShares$1.75 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny271KShares$1.53 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA223KShares$1.26 Million0.0% of portfolio
-
American Financial Group Inc180KShares$1.02 Million0.25% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $65.4M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...